T1	Participants 53 119	men with moderate chronic renal insufficiency and coronary disease
T2	Participants 342 391	ndividuals with chronic renal insufficiency (CRI)
T3	Participants 638 662	people with moderate CRI
T4	Participants 717 778	Veterans Affairs High-Density Lipoprotein Intervention Trial,
T5	Participants 844 1048	2,531 men with coronary disease, HDL-C levels of 40 mg/dL or less (< or =1.0 mmol/L), low-density lipoprotein cholesterol levels of 140 mg/dL or less (< or =3.6 mmol/L), and a range of triglyceride values
T6	Participants 1415 1493	1,981 individuals, of whom 399 individuals (20.2%) were eligible for inclusion
T7	Participants 2216 2274	5 subjects with acute increases in serum creatinine levels
T8	Participants 2639 2720	individuals with moderate CRI, low HDL-C levels, and concomitant coronary disease
